ImageneBio CFO Yanina Grant-Huerta files insider report

ImageneBio, Inc. filed an initial Form 3 identifying Yanina Grant-Huerta as its Chief Financial Officer and reporting person.

Accepted by SEC EDGAR 07/28/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ImageneBio, Inc. filed an initial Form 3 identifying Yanina Grant-Huerta as its Chief Financial Officer and reporting person. The data shows no insider transactions, holdings entries, or derivative positions, and references an Exhibit 24 Power of Attorney authorizing filings on her behalf.

Key Figures

Insider buy transactions: 0 Insider sell transactions: 0 Reported holdings entries: 0 +2 more

5 metrics

Insider buy transactions 0 buyCount in the transactionSummary for this Form 3

Insider sell transactions 0 sellCount in the transactionSummary for this Form 3

Reported holdings entries 0 holdingEntries in the transactionSummary, indicating no holdings rows

Derivative transactions 0 derivativeTransactionCount in the transactionSummary

Net shares bought/sold 0 netBuySellShares reported for this insider in the filing data

Key Terms

Power of Attorney, Chief Financial Officer, Exhibit 24

3 terms

Power of Attorney regulatory

"Remarks state: "Exhibit 24 - Power of Attorney.""

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

Chief Financial Officer financial

"Officer title for Yanina Grant-Huerta is "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

Exhibit 24 regulatory

"Remarks reference "Exhibit 24 - Power of Attorney.""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ImageneBio (IMA)'s Form 3 filing disclose?

The Form 3 identifies Yanina Grant-Huerta as ImageneBio’s Chief Financial Officer and reporting person. It lists zero insider transactions, zero holdings entries, and no derivative positions, functioning as an initial beneficial ownership report for this officer.

Are any insider share transactions reported in ImageneBio (IMA)'s Form 3?

No, the filing reports 0 buy and 0 sell transactions for Yanina Grant-Huerta. The transaction summary also shows no exercises, gifts, restructurings, or derivative transactions, indicating no trading activity is captured in this insider report.

Does ImageneBio (IMA)'s Form 3 show any derivative positions?

No, the Form 3 data lists 0 derivative transactions and an empty derivative position summary. This means no options, warrants, or other derivative securities are reported for the Chief Financial Officer in this particular ownership statement.

Who is the reporting person in ImageneBio (IMA)'s Form 3?

The reporting person is Yanina Grant-Huerta, designated as Chief Financial Officer of ImageneBio, Inc. She is not identified as a director or 10% owner in the data, but appears solely in her capacity as an executive officer.

What is the significance of Exhibit 24 in ImageneBio (IMA)'s Form 3?

The remarks reference “Exhibit 24 - Power of Attorney,” indicating a Power of Attorney related to the filing. This typically authorizes another party to sign and submit ownership reports on the officer’s behalf under specified conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Grant-Huerta Yanina

(Last) (First) (Middle)

C/O IMAGENEBIO, INC.

12526 HIGH BLUFF DRIVE, SUITE 345

(Street)

SAN DIEGO CALIFORNIA 92130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2026

3. Issuer Name and Ticker or Trading Symbol
ImageneBio, Inc. [ IMA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney.

No securities are beneficially owned.

	/s/ Kristin Yarema, Attorney-in-Fact	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)